Genomic Scores Are Independent of Disease Volume in Men With Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance

Journal of Urology - Netherlands
doi 10.1016/j.juro.2017.09.077
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable-Risk Men During Active Surveillance

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2017English

SS8 Active Surveillance for Men With Newly Diagnosed Prostate Cancer : Critical Role of Pathology

Japanese Journal of Urology
Urology
2011English

Insignificant Disease Among Men With Intermediate-Risk Prostate Cancer

World Journal of Urology
Urology
2014English

Pd28-10 Multiparametric-Mri Prior to Repeat Biopsy for Active Surveillance Can Identify Men With High-Risk Prostate Cancer

Journal of Urology
Urology
2017English

Confirmatory Biopsy for the Assessment of Prostate Cancer in Men Considering Active Surveillance: Reference Centre Experience

ecancermedicalscience
Cancer ResearchOncology
2016English

Why Men With a Low-Risk Prostate Cancer Select and Stay on Active Surveillance: A Qualitative Study

PLoS ONE
Multidisciplinary
2019English

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using a Clinical Cell-Cycle Risk Score

Personalized Medicine
MedicineMolecular MedicinePharmacology
2019English

Active Surveillance for Prostate Cancer

International Journal of Urology
Urology
2015English

Radical Radiotherapy for High-Risk Prostate Cancer in Older Men

Oncologist
Cancer ResearchMedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy